Spring Bank Pharmaceuticals, Inc. 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Aug 16, 2016
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-08-15$11.43/sh+1,800$20,574→ 35,650 total - Purchase
Common Stock
2016-08-16$11.49/sh+100$1,149→ 35,750 total